Honored to receive the Outstanding Poster Presenter award at #ACG2024 Grateful for the inspiring conversations and incredible people I met along the way. Here’s to more learning and growing in GI! #ACG#GITwitter#GIcommunity
Honored to receive the “Outstanding Poster Presenter Award” for our study on Acute Pancreatitis in HIV patients. Grateful to have worked with Dr. Asfari and the incredible GI team at @AdventHealth!
@MN_GIMD#ACG#MedTwitter
🚨With #Match2026 season underway for some & beginning for others, remember:
🤝 Don’t wait for a title to be a mentor
💡 Believe in their mission & vision, not just credentials
🎉 Celebrate small wins, they matter
The impact you make today becomes how they lift others tomorrow.
June 2024 — wrapped up PGY-1 with the Intern of the Year award. Now, one year later, I’ve just started my #GI fellowship application. Hard to believe how fast time flies. Grateful for every step of this journey, and beyond excited for what’s ahead 🙌
Thrilled to share our video just published in @ACGCRJ!
Forever grateful to my mentor Dr. Berzosa for his guidance, and big thanks to Dr. @SunilAminMD, Dr. @seanbhalla, and Dr. Mahfouz for their invaluable feedback that helped shape the final product
https://t.co/uKG7Ppq6CY
Incredible win 🙌 for our #GIsocities & community !
This is a good next step in continuous fight against early #GIcancers !
🙏 to @AmCollegeGastro & @ASGEendoscopy for their advocacy !
More work to do - but steps in the right direction !
“First, do no harm.”
Time to rethink our secondary #SBP prophylaxis?!
Silvey et al (@AmJGastro 05/2025) studied 11k+ cirrhotics: secondary SBP prophylaxis ↑ recurrence by > 60 % with no survival gain and climbing FQ resistance.
Great study! #GITwitter#MedTwitter
In the #RedJournal:
Higher Rate of Spontaneous Bacterial Peritonitis Recurrence With Secondary Spontaneous Bacterial Peritonitis Prophylaxis Compared With No Prophylaxis in 2 National Cirrhosis Cohorts
Silvey, et al.
📕 https://t.co/SROILuTzc8
@JasmohanBajaj@MLongMD
“You treat my eyes, you’re treating my Crohn’s.”
A moving reminder of what #IBD patients truly need, a holistic, whole-person care.
#Gastroenterology#GITwitter#MedTwitter
Original Article: Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis (ESSENCE trial) https://t.co/8zxann2S8C
#Endocrinology#Gastroenterology
From GHA ➡️ A 77-year-old female was found to have massive gastric dilation due to recurrent benign idiopathic pre-pyloric stenosis and was managed with lumen-apposing metal stent.
🔗 https://t.co/3HTpzlUIcb
✨ The April Editor's Essential Reading examines the effect of an #endoscopy screening on upper gastrointestinal cancer mortality. Read the full article here: https://t.co/IJZyFPcTbi